The Impact of Lifestyle Diseases
Lifestyle diseases, such as obesity and diabetes, are a major driver of the Blood thinning Drugs Market. Both of these conditions are significant risk factors for cardiovascular diseases, including heart attacks and strokes. Obese individuals are at a higher risk for developing venous thromboembolism, while people with diabetes often have a higher risk of developing atherosclerotic plaques that can lead to arterial clots.
The global epidemic of obesity and the rising incidence of diabetes are therefore creating a huge and expanding patient population that requires blood thinning therapy. As these health crises continue to grow, the demand for effective and safe blood thinning drugs is expected to increase proportionally.
11 Ansichten
